Can Esketamine and ECT Be Combined? What a Small New Study Shows
· Updated November 2026 · Aazaz Haq, MD
For people with severe depression who improve only partly with one treatment, a natural question is whether two treatments together could do better. A small study published in 2026 looked at combining esketamine with electroconvulsive therapy (ECT). It is worth understanding, as long as we are honest about how small it was.
The short answer
A 2026 case series of four patients with severe depression found that combining esketamine with ECT was well tolerated and associated with substantial improvement. Four patients cannot prove the combination works, but it supports a proper trial and reflects a broader truth: severe depression sometimes needs more than one treatment.
A quick word on ECT
ECT is the most effective treatment we have for severe depression. Under general anesthesia, a brief electrical current triggers a controlled seizure. A course is usually two to three sessions a week for several weeks. Its main drawbacks are anesthesia, the logistics of treatment, and temporary memory problems for some people.
We do not provide ECT at our clinic, but we discuss it with patients because it belongs in the treatment plan for some people. When it is the right option, we refer to a program that offers it.
What the study did
A team at Bellvitge University Hospital in Spain treated four adults, ages 50 to 72, with severe treatment-resistant depression. Each had improved only partly with either ECT or esketamine alone. They received both, on a coordinated schedule, for 24 weeks. ECT was gradually spaced out while esketamine continued weekly or every two weeks.
On average, depression scores fell by about 58%, and no one relapsed during the study. Side effects were the expected ones: mild dissociation after esketamine and some confusion after ECT. No serious adverse events were reported.
How I read it
Four patients is a case series, not a trial. There was no comparison group, and people with severe depression can improve over 24 weeks for many reasons. So this study does not show that the combination works. It shows that it was tolerated in a few carefully monitored patients and that it deserves a proper trial.
That fits a broader principle I believe in: treatment-resistant depression is rarely solved by one intervention. Persistence, careful sequencing, and sometimes combining treatments are what move people forward.
Related evidence worth knowing
A 2023 randomized trial compared IV ketamine with ECT in people with treatment-resistant depression without psychosis. Ketamine was as effective as ECT over three weeks, with fewer memory side effects. ECT remains the stronger choice in some situations, such as psychotic depression or catatonia.
What this means for you
If you have improved partly with esketamine, TMS or ECT, that partial response is useful information, not a dead end. Our guide to what happens if one treatment does not work explains how we think about next steps. To talk through your own situation, request a consultation call.
Questions I hear often
If I have had ECT before, can I try esketamine?
Yes. A history of ECT does not rule out esketamine or TMS. In fact, how you responded to ECT, fully, partly or not at all, helps us plan what to try next.
Can esketamine replace maintenance ECT?
For some people it may, but this has not been tested in large trials. Maintenance ECT works well for many people who relapse after a course. Decisions about stopping or replacing it should be made carefully, with the clinicians who know your history.
Why don't you provide ECT?
ECT requires anesthesia and a hospital or surgical setting. Our clinic focuses on outpatient treatments that do not need anesthesia. When ECT is the right choice, we refer to programs that provide it and stay involved where that helps.
How we think about combining treatments
Most people do not need combined treatment. But for people with severe depression who have improved only partly, combining approaches can make sense: an antidepressant with esketamine, TMS with therapy, or medication adjustments alongside a neuromodulation course. We add one change at a time when we can, so we know what is helping. And we measure symptoms regularly, because good intentions are not a substitute for data.
If you are a clinician caring for someone in this situation, our clinician guide When Depression Treatment Stalls lays out how we approach it.
References
- Case series of combined esketamine and electroconvulsive therapy in four adults with severe treatment-resistant depression, Bellvitge University Hospital, Spain. 2026 (PubMed 41609468). Source
- Anand A, et al. Ketamine versus ECT for nonpsychotic treatment-resistant major depression (ELEKT-D). N Engl J Med. 2023. PubMed
- UK ECT Review Group. Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet. 2003. PubMed